Rankings
▼
Calendar
KYMR Q1 2020 Earnings — Kymera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
KYMR
Kymera Therapeutics, Inc.
$7B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
$3M
100.0% margin
Operating Income
-$11M
-328.1% margin
Net Income
-$11M
-318.9% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
+87.0%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$13M
Stock-Based Comp.
$371,000
← FY 2020
All Quarters
Q2 2020 →